Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-17 23:27 |
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its …
|
English | 205.1 KB | ||
| 2024-07-17 23:27 |
Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND…
|
French | 219.3 KB | ||
| 2024-07-03 07:00 |
Press Release: Dupixent approved in the EU as the first-ever targeted therapy f…
|
English | 271.7 KB | ||
| 2024-07-03 07:00 |
Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour l…
|
French | 289.6 KB | ||
| 2024-07-02 20:25 |
6-K
|
English | 71.3 KB | ||
| 2024-06-28 22:26 |
FORM 11-K
|
English | 52.1 KB | ||
| 2024-06-28 22:22 |
FORM 11-K
|
English | 51.6 KB | ||
| 2024-06-26 23:30 |
Communiqué de presse : Publication dans le NEJM des données positives de phase …
|
French | 295.2 KB | ||
| 2024-06-26 23:30 |
Press Release: Dupixent positive phase 3 data in children one to 11 years of ag…
|
English | 245.1 KB | ||
| 2024-06-25 19:32 |
Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 »
|
French | 151.7 KB | ||
| 2024-06-25 19:32 |
Press Release: Availability of the Q2 2024 Aide-mémoire
|
English | 148.3 KB | ||
| 2024-06-21 09:30 |
Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corpora…
|
French | 147.6 KB | ||
| 2024-06-21 09:30 |
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs…
|
English | 136.5 KB | ||
| 2024-06-21 07:00 |
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for…
|
English | 213.6 KB | ||
| 2024-06-21 07:00 |
Communiqué de presse : ISTH : De nouvelles données sur ALTUVIIIO et le fitusira…
|
French | 247.0 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
